Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2 | N/A | N/A | N/A | N/A |
| Marketable Securities | 65,825 | N/A | N/A | N/A | N/A |
| TOTAL | $65,904 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 25 | 0 | 0 | 0 | 0 |
| TOTAL | $25 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $65,929 | $N/A | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,769 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 286 | N/A | N/A | N/A | N/A |
| TOTAL | $2,996 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 12,763 | 0 | 0 | 0 | 0 |
| TOTAL | $12,763 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $15,758 | $N/A | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 1 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | -444 | 0 | 0 | 0 | 0 |
| TOTAL | $50,171 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $65,929 | $0 | $0 | $0 | $0 |